Timolol maleate
FDA Approved
Contents
Description
Timolol is a non-selective beta-adrenergic receptor blocking agent used to reduce elevated intraocular pressure. It is commonly prescribed for glaucoma and ocular hypertension. In patients with Harboyan syndrome experiencing corneal edema and secondary glaucoma, timolol can help manage intraocular pressure.
Indications & Therapeutic Use
elevated intraocular pressure, open-angle glaucoma, ocular hypertension
Linked Diseases:
Harboyan syndrome
C535473
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Timolol maleate — GNH India
128 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Arutimol
EU
Blocadren
EU
Cusimolol
EU
Dibetop
EU
Dispatim
EU
Dispatim Sine
EU
Droptimol
EU
Eyopto
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Timolol maleate
| Generic Name | Timolol maleate |
| Brands | 1 brand available |
| Active Ingredient | Timolol maleate |
| Drug Class | elevated intraocular pressure |
| Manufacturer | Bausch + Lomb |
| Dosage Forms | Ophthalmic solution, 0.25%, 0.5% |
| Medical Code | S01ED01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved |
| Countries | 8 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations9 Validated Nodes